[1] |
Sung H,Ferlay J,Siegel RL,et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries[J]. CA Cancer J Clin,2021,71(3): 209-249.
|
[2] |
Digklia A,Wagner AD. Advanced gastric cancer: Current treatment landscape and future perspectives[J]. World J Gastroenterol,2016,22(8): 2403-2414.
|
[3] |
Wang FH,Zhang XT,Li YF,et al. The Chinese Society of Clinical Oncology(CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer,2021[J]. Cancer Commun(Lond),2021,41(8): 747-795.
|
[4] |
陆晓峰,刘颂,艾世超,等. 纳米碳与吲哚菁绿导航腹腔镜胃癌根治术淋巴结清扫的对比性研究[J/CD]. 中华普外科手术学杂志(电子版),2021,15(02): 146-149.
|
[5] |
笈康康,陶亮,王峰,等. 预测T4a期胃癌腹膜转移危险因素的列线图模型的建立与验证[J/CD]. 中华普外科手术学杂志(电子版),2023,17(01): 40-45.
|
[6] |
Liu S,He J,Liu S,et al. Radiomics analysis using contrast-enhanced CT for preoperative prediction of occult peritoneal metastasis in advanced gastric cancer[J]. Eur Radiol,2020,30(1): 239-246.
|
[7] |
Zhao L,Pang Y,Luo Z,et al. Role of[(68)Ga]Ga-DOTA-FAPI-04 PET/CT in the evaluation of peritoneal carcinomatosis and comparison with[(18)F]-FDG PET/CT[J]. Eur J Nucl Med Mol Imaging,2021,48(6): 1944-1955.
|
[8] |
Li C,Tian Y,Chen J,et al. Usefulness of[(68)Ga]FAPI-04 and[(18)F]FDG PET/CT for the detection of primary tumour and metastatic lesions in gastrointestinal carcinoma: a comparative study[J]. Eur Radiol,2023,33(4): 2779-2791.
|
[9] |
杨正阳,刘颂,艾世超,等. 新型PET-CT探针在胃癌应用中的现状与进展[J/CD]. 中华普外科手术学杂志(电子版),2019,13(02): 209-214.
|
[10] |
Mariette C,Carneiro F,Grabsch HI,et al. Consensus on the pathological definition and classification of poorly cohesive gastric carcinoma[J]. Gastric Cancer,2019,22(1): 1-9.
|
[11] |
Brenkman HJF,Gertsen EC,Vegt E,et al. Evaluation of PET and laparoscopy in STagIng advanced gastric cancer: a multicenter prospective study(PLASTIC-study)[J]. BMC Cancer,2018,18(1): 450.
|
[12] |
Liu Q,Li J,Xin B,et al.(18)F-FDG PET/CT Radiomics for Preoperative Prediction of Lymph Node Metastases and Nodal Staging in Gastric Cancer[J]. Front Oncol,2021,11: 723345.
|
[13] |
Bae SW,Berlth F,Jeong KY,et al. Glucose metabolic profiles evaluated by PET associated with molecular characteristic landscape of gastric cancer[J]. Gastric Cancer,2022,25(1): 149-160.
|
[14] |
Liu Z,Tian H,Zhu Z. Application of Circulating Tumor Cells and Interleukin-6 in Preoperative Prediction of Peritoneal Metastasis of Advanced Gastric Cancer[J]. J Inflamm Res,2023,16: 3033-3047.
|
[15] |
Li W,Jiang Z,Cui N,et al. Superiority of FAPI-PET/CT for examining multiple malignant tumors: a retrospective study[J]. Am J Cancer Res,2023,13(10): 4547-4559.
|
[16] |
Nagtegaal ID,Odze RD,Klimstra D,et al. The 2019 WHO classification of tumours of the digestive system[J]. Histopathology,2020,76(2): 182-188.
|
[17] |
Kijan C,Hugen S,Thomas RE,et al. The Histopathological Characteristic of Gastric Carcinoma in the Belgian Tervueren and Groenendael Dog: A Comparison of Two Classification Methods[J]. Animals(Basel),2023,13(9): 1532.
|
[18] |
Miao Y,Feng R,Guo R,et al. Utility of[(68)Ga]FAPI-04 and[(18)F]FDG dual-tracer PET/CT in the initial evaluation of gastric cancer[J]. Eur Radiol,2023,33(6): 4355-4366.
|
[19] |
Koppula BR,Fine GC,Salem AE,et al. PET-CT in Clinical Adult Oncology: III. Gastrointestinal Malignancies[J]. Cancers(Basel),2022,14(11): 2668.
|
[20] |
Kozaka K,Kobayashi S,Takamura H,et al. Differences in 18F-FDG Uptake and Expression of Glucose Transporter Between 2 Distinct Subtypes of Mass-Forming Intrahepatic Cholangiocarcinomas[J]. Clin Nucl Med,2020,45(6): e267-e273.
|
[21] |
Zhang Z,Huang Y,Li S,et al. Comprehensive analysis based on glycolytic and glutaminolytic pathways signature for predicting prognosis and immunotherapy in ovarian cancer[J]. J Cancer,2024,15(2): 383-400.
|
[22] |
Ge S,Xia X,Ding C,et al. Author Correction: A proteomic landscape of diffuse-type gastric cancer[J]. Nat Commun,2018,9(1): 1850.
|
[23] |
Baj J,Korona-Glowniak I,Forma A,et al. Mechanisms of the Epithelial-Mesenchymal Transition and Tumor Microenvironment in Helicobacter pylori-Induced Gastric Cancer[J]. Cells,2020,9(4): 1055.
|
[24] |
Yoon JK,Kang WJ. Modulation of FDG Uptake by Cell Cycle Synchronization Using a T-Type Calcium Channel Inhibitor[J]. Cancers(Basel),2023,15(21): 5244.
|
[25] |
Lee D,Ham IH,Oh HJ,et al. Tubulointerstitial nephritis antigen-like 1 from cancer-associated fibroblasts contribute to the progression of diffuse-type gastric cancers through the interaction with integrin beta1[J]. J Transl Med,2024,22(1): 154.
|
[26] |
Vander Heiden MG,Cantley LC,Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation[J]. Science,2009,324(5930): 1029-1033.
|
[27] |
Nyakale N,Filippi L,Aldous C,et al. Update on PET Radiopharmaceuticals for Imaging Hepatocellular Carcinoma[J]. Cancers(Basel),2023,15(7): 1975.
|
[28] |
Chen BY,Ghezzi C,Villegas B,et al.(18)F-FAC PET Visualizes Brain-Infiltrating Leukocytes in a Mouse Model of Multiple Sclerosis[J]. J Nucl Med,2020,61(5): 757-763.
|
[29] |
Zhang Z,Liu S,Ma H,et al. Propionic Acid-Based PET Imaging of Prostate Cancer[J]. Mol Imaging Biol,2021,23(6): 836-845.
|
[30] |
Vassileva V,Braga M,Barnes C,et al. Effective Detection and Monitoring of Glioma Using[(18)F]FPIA PET Imaging[J]. Biomedicines,2021,9(7): 811.
|
[31] |
Wang C,Yang Z,Xu E,et al. Apolipoprotein C-II induces EMT to promote gastric cancer peritoneal metastasis via PI3K/AKT/mTOR pathway[J]. Clin Transl Med,2021,11(8): e522.
|
[32] |
Gyamfi J,Yeo JH,Kwon D,et al. Interaction between CD36 and FABP4 modulates adipocyte-induced fatty acid import and metabolism in breast cancer[J]. NPJ Breast Cancer,2021,7(1): 129.
|